J Biol Chem. 2014 Jul 25;289(30):20939-52. doi: 10.1074/jbc.M114.553743.
Our understanding of the molecular events contributing to myogenic control of diameter in cerebral resistance arteries in response to changes in intravascular pressure, a fundamental mechanism regulating blood flow to the brain, is incomplete. Myosin light chain kinase and phosphatase activities are known to be increased and decreased, respectively, to augment phosphorylation of the 20-kDa regulatory light chain subunits (LC20) of myosin II, which permits cross-bridge cycling and force development. Here, we assessed the contribution of dynamic reorganization of the actin cytoskeleton and thin filament regulation to the myogenic response and serotonin-evoked constriction of pressurized rat middle cerebral arteries. Arterial diameter and the levels of phosphorylated LC(20), calponin, caldesmon, cofilin, and HSP27, as well as G-actin content, were determined. A decline in G-actin content was observed following pressurization from 10 mm Hg to between 40 and 120 mm Hg and in three conditions in which myogenic or agonist-evoked constriction occurred in the absence of a detectable change in LC20 phosphorylation. No changes in thin filament protein phosphorylation were evident. Pressurization reduced G-actin content and elevated the levels of cofilin and HSP27 phosphorylation. Inhibitors of Rho-associated kinase and PKC prevented the decline in G-actin; reduced cofilin and HSP27 phosphoprotein content, respectively; and blocked the myogenic response. Furthermore, phosphorylation modulators of HSP27 and cofilin induced significant changes in arterial diameter and G-actin content of myogenically active arteries. Taken together, our findings suggest that dynamic reorganization of the cytoskeleton involving increased actin polymerization in response to Rho-associated kinase and PKC signaling contributes significantly to force generation in myogenic constriction of cerebral resistance arteries.
我们对于分子事件的理解还不完全,这些分子事件导致了颅内压变化时脑血管阻力的直径发生肌源性控制,这是调节脑血流的基本机制。肌球蛋白轻链激酶和磷酸酶的活性分别增加和减少,以增强肌球蛋白 II 的 20kDa 调节轻链亚基(LC20)的磷酸化,从而允许横桥循环和力的产生。在这里,我们评估了肌球蛋白原性反应和 5-羟色胺诱发的加压大鼠大脑中动脉收缩中肌动蛋白细胞骨架的动态重排和薄丝调节的贡献。测量了动脉直径和磷酸化 LC(20)、钙调蛋白、钙调蛋白、原肌球蛋白和 HSP27 的水平,以及 G-肌动蛋白含量。从 10mmHg 加压到 40-120mmHg 时,以及在三种情况下,当肌原性或激动剂诱发的收缩在 LC20 磷酸化没有检测到变化时,观察到 G-肌动蛋白含量下降。薄丝蛋白磷酸化没有变化。加压降低了 G-肌动蛋白含量并增加了原肌球蛋白和 HSP27 磷酸化的水平。Rho 相关激酶和 PKC 的抑制剂可防止 G-肌动蛋白下降;分别降低原肌球蛋白和 HSP27 磷酸蛋白含量;并阻止肌原性反应。此外,HSP27 和原肌球蛋白磷酸化调节剂可显著改变具有肌原性活性的动脉的动脉直径和 G-肌动蛋白含量。总之,我们的发现表明,涉及 Rho 相关激酶和 PKC 信号转导的细胞骨架的动态重排导致肌球蛋白原性收缩中肌动蛋白聚合增加,这对脑阻力动脉的力产生有重要贡献。